Compound information
- Natural Products
- ZC216715
- Molecular Formula
- C15H19N3O5S
- Molecular Weight
- 353.104541708 g/mol
- Structure
-
- IUPAC Name
- (Z)-4-[4-(4-methylpiperazin-1-yl)sulfonylanilino]-4-oxo-but-2-enoic acid
- InChI
- InChI=1S/C15H19N3O5S/c1-17-8-10-18(11-9-17)24(22,23)13-4-2-12(3-5-13)16-14(19)6-7-15(20)21/h2-7H,8-11H2,1H3,(H,16,19)(H,20,21)/b7-6-
- InChI Key
- QZBAALRRMMUOIK-SREVYHEPSA-N
- SMILES
- CN1CCN(S(=O)(=O)c2ccc(NC(=O)/C=C\C(=O)O)cc2)CC1
- Source
- ZINC000004657164
Warheads
- Acrylamide
-
- Acrylate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 107.02 Å2 | LogP | -0.17 |
LogS | -2.252 | LogD | -0.171 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.003 | Pgp substrate | 0.306 |
HIA | 0.96 | F20 % | 0.988 |
F30 % | 0.543 | Caco-2 | -5.343 |
MDCK | -5.369 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.015 | PPB | 39.076 |
VD | 1.408 | Fu | 0.235 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.002 | CYP1A2 substrate | 0.671 |
CYP2A6 substrate | 0.449 | CYP2B6 substrate | 0.543 |
CYP2C19 inhibitor | 0.013 | CYP2C19 substrate | 0.71 |
CYP2C8 substrate | 0.764 | CYP2C9 inhibitor | 0.039 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.046 |
CYP2D6 substrate | 0.75 | CYP2E1 substrate | 0.67 |
CYP3A4 inhibitor | 0.015 | CYP3A4 substrate | 0.706 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.561 | CL | 4.174 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.467 | Hepatotoxicity | 0.395 |
Mutagenicity | 0.003 | Rat Oral Acute Toxicity | 0.019 |
FDAMDD | 0.103 | Skin Sensitization | 0.377 |
Carcinogenicity | 0.023 | Eye Corrosion | 0.002 |
Eye Irritation | 0.082 | Respiratory Toxicity | 0.059 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.616 | IGC50 | 1.811 |
LC50FM | -3.144 | LC50DM | -0.15 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.161 | NR-AR-LBD | 0.333 |
NR-AhR | 0.011 | NR-Aromatase | 0.015 |
NR-ER | 0.136 | NR-ER-LBD | 0.275 |
NR-PPAR-gamma | 0.092 | SR-ARE | 0.507 |
SR-ATAD5 | 0.286 | SR-HSE | 0.003 |
SR-MMP | 0.007 | SR-p53 | 0.056 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.